TNF Pharmaceuticals advances clinical trials for isomyosamine in sarcopenia and GLP-1-induced frailty

Johnson & Johnson submits New Drug Application for TAR-200 to treat bladder cancer

Talphera reaches FDA agreement for Prior Approval Supplement review to reduce patient numbers in Niyad study

Phase I/II clinical trial of Ariceum Therapeutics' 225Ac-SSO110 gets US FDA approval

Adaptive Biotechnologies and NeoGenomics partner to expand MRD monitoring for blood cancer

BioArctic reports FDA acceptance of BLA for for subcutaneous maintenance dosing of Leqembi

Elicera Therapeutics receives ODD for ELC-100

ReciBioPharm secures grant to expand RNA manufacturing in LMICs

Johnson & Johnson agrees acquisition of Intra-Cellular Therapies Inc

Nuformix submits Orphan Drug Application for NXP002 in IPF

GSK to acquire IDRx for USD1.15bn to advance GIST treatment

Daiichi Sankyo and AstraZeneca's datopotamab deruxtecan receives US Priority Review for EGFR-mutated NSCLC

American Injectables gains FDA approval

Johnson & Johnson granted Priority Review for nipocalimab in gMG

Rigel Pharmaceuticals granted Orphan Drug designation for R289 in myelodysplastic syndromes